News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
883,418 Results
Type
Article (88756)
Company Profile (816)
Press Release (793824)
Multimedia
Podcasts (236)
Webinars (35)
Section
Business (233581)
Career Advice (4162)
Deals (39983)
Drug Delivery (177)
Drug Development (91695)
Employer Resources (207)
FDA (18552)
Job Trends (17484)
News (398709)
Policy (40013)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3053)
Academic (2)
Accelerated approval (56)
ADA (47)
Adcomms (40)
Allergies (194)
Alliances (56989)
ALS (234)
Alzheimer's disease (1962)
Antibody-drug conjugate (ADC) (550)
Approvals (18884)
Artificial intelligence (860)
ASCO (345)
Autoimmune disease (354)
Automation (63)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (248)
Biotechnology (480)
Bladder cancer (211)
Brain cancer (84)
Breast cancer (835)
Cancer (6528)
Cardiovascular disease (551)
Career advice (3597)
Career pathing (52)
CAR-T (381)
CDC (76)
Celiac Disease (3)
Cell therapy (1061)
Cervical cancer (53)
Clinical research (78934)
Collaboration (2345)
Company closure (8)
Compensation (1503)
Complete response letters (105)
COVID-19 (3039)
CRISPR (123)
C-suite (1267)
Cystic fibrosis (167)
Data (8623)
Decentralized trials (3)
Denatured (90)
Depression (192)
Dermatology (96)
Diabetes (694)
Diagnostics (7584)
Digital health (67)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (420)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (315)
Earnings (102478)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (138569)
Executive appointments (1188)
FDA (22590)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (19)
Frontotemporal dementia (36)
Funding (1918)
Gene editing (269)
Generative AI (89)
Gene therapy (846)
GLP-1 (1281)
Government (5557)
Grass and pollen (8)
Guidances (419)
Healthcare (21249)
Hematology (198)
HIV (92)
Huntington's disease (64)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (352)
Immuno-oncology (114)
Indications (203)
Infectious disease (3433)
Inflammatory bowel disease (241)
Inflation Reduction Act (17)
Influenza (148)
Intellectual property (316)
Interviews (821)
IPO (17998)
IRA (61)
Job creations (5208)
Job search strategy (2871)
JPM (73)
Kidney cancer (23)
Labor market (120)
Layoffs (685)
Leadership (53)
Legal (10171)
Liver cancer (110)
Longevity (36)
Lung cancer (868)
Lymphoma (462)
Machine learning (66)
Management (66)
Manufacturing (1207)
MASH (223)
Medical device (15267)
Medtech (15418)
Mergers & acquisitions (23270)
Metabolic disorders (1807)
mRNA (263)
Multiple sclerosis (204)
NASH (24)
Neurodegenerative disease (501)
Neuropsychiatric disorders (126)
Neuroscience (3693)
Neurotech (2)
NextGen: Class of 2026 (7715)
Non-profit (5142)
Now hiring (80)
Obesity (865)
Opinion (373)
Ovarian cancer (242)
Pain (283)
Pancreatic cancer (346)
Parkinson's disease (413)
Partnered (39)
Patents (648)
Patient recruitment (741)
Peanut (70)
People (67949)
Pharmaceutical (136)
Pharmacy benefit managers (37)
Phase 1 (24396)
Phase 2 (34286)
Phase 3 (25786)
Pipeline (9631)
Policy (396)
Postmarket research (3559)
Preclinical (10972)
Press Release (72)
Prostate cancer (343)
Psychedelics (68)
Radiopharmaceuticals (370)
Rare diseases (1253)
Real estate (7462)
Recruiting (81)
Regulatory (30340)
Reports (77)
Research institute (2768)
Resumes & cover letters (654)
Rett syndrome (42)
RNA editing (29)
RSV (98)
Schizophrenia (195)
Series A (324)
Series B (233)
Service/supplier (28)
Sickle cell disease (127)
Special edition (32)
Spinal muscular atrophy (190)
Sponsored (55)
Startups (4370)
State (2)
Stomach cancer (21)
Supply chain (144)
Tariffs (104)
The Weekly (143)
Vaccines (1301)
Venture capital (131)
Weight loss (592)
Women's health (139)
Worklife (24)
Date
Today (160)
Last 7 days (746)
Last 30 days (3241)
Last 365 days (33228)
2026 (15780)
2025 (33219)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (102)
Alaska (7)
Arizona (397)
Arkansas (16)
Asia (52262)
Australia (9188)
California (14303)
Canada (3994)
China (1555)
Colorado (613)
Connecticut (637)
Delaware (441)
Europe (120510)
Florida (2118)
Georgia (465)
Hawaii (4)
Idaho (70)
Illinois (1237)
India (102)
Indiana (661)
Iowa (25)
Japan (584)
Kansas (143)
Kentucky (56)
Louisiana (62)
Maine (89)
Maryland (1736)
Massachusetts (10447)
Michigan (421)
Minnesota (796)
Mississippi (7)
Missouri (163)
Montana (37)
Nebraska (30)
Nevada (152)
New Hampshire (92)
New Jersey (3789)
New Mexico (35)
New York (3756)
North Carolina (1927)
North Dakota (11)
Northern California (7101)
Ohio (443)
Oklahoma (26)
Oregon (55)
Pennsylvania (2821)
Puerto Rico (30)
Rhode Island (54)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5615)
Tennessee (226)
Texas (2327)
United States (51142)
Utah (425)
Vermont (1)
Virginia (363)
Washington D.C. (89)
Washington State (1176)
West Virginia (4)
Wisconsin (157)
Wyoming (2)
There are 883,418 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Health Canada authorizes Lunsumio® (mosunetuzumab) for the treatment of relapsed or refractory follicular lymphoma after two or more systemic therapies
June 8, 2026
·
5 min read
Press Releases
Kaiser Permanente physician leader Maria Ansari, MD, FACC, selected for Modern Healthcare’s 2026 list of 50 Most Influential Clinical Executives
June 8, 2026
·
5 min read
Press Releases
CNS Pharmaceuticals CFO, Steve O’Loughlin, Highlights Company’s Recent $22.5M Financing in Virtual Investor “What This Means” Segment
June 8, 2026
·
3 min read
Press Releases
ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data Supporting the Ongoing Phase 3 STOP-HAE Clinical Trial at the 2026 Annual EAACI Congress
June 8, 2026
·
3 min read
Press Releases
TOMI Environmental Targets Drone-Enabled SteraMist® Technology for High-Growth AI, Autonomous Robotics and Biosecurity Markets
June 8, 2026
·
9 min read
Press Releases
Capricor Therapeutics to Present at Upcoming Investor Conferences - June 8, 2026
June 8, 2026
·
3 min read
Events
AnalytiCon
Join life science analytics, data, and AI leaders in Boston for three days of practical strategies, real-world use cases, and peer learning focused on advancing AI-powered decision-making.
June 8, 2026
Series B
City Therapeutics builds RNAi pipeline with $99.5M series B
City Therapeutics, one of
BioSpace
’s NextGen companies for 2026, was started by RNA royalty John Maraganore, former CEO of Alnylam.
June 8, 2026
·
2 min read
·
Tristan Manalac
Obesity
ADA: Novo boasts deep pipeline, ‘breadth of assets’ after analysts award Lilly weight loss gold
Novo Nordisk and Eli Lilly presented data extolling the benefits of their relative weight loss therapies in obesity-linked indications, while analysts at BMO Capital Markets were “encouraged” by the strategy communicated by Novo management.
June 8, 2026
·
5 min read
·
Heather McKenzie
Deals
J&J glows with $1B buyout of Firefly and its degrader platform tech
The acquisition gives Johnson & Johnson access to Firefly Bio’s next-gen platform designed to create degrader antibody conjugates that can crack the tricky KRAS cancer target.
June 8, 2026
·
1 min read
·
Gabrielle Masson
1 of 88,342
Next
